Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild to Moderate”

2,406 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,406 results

Testing effectiveness (Phase 2)Study completedNCT01591044
What this trial is testing

A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma

Who this might be right for
Asthma
Rigel Pharmaceuticals 301
Not applicableStudy completedNCT05385016
What this trial is testing

Cooking Classes for Young Adults With ID

Who this might be right for
Intellectual Disability, Mild to Moderate
University of Kansas Medical Center 21
Not applicableAvailableNCT04657406
What this trial is testing

Expanded Access to Zofin for Patients With COVID-19

Who this might be right for
Covid19Corona Virus InfectionSARS (Severe Acute Respiratory Syndrome)+1 more
ZEO ScientifiX, Inc.
Testing effectiveness (Phase 2)Study completedNCT02022215
What this trial is testing

Efficacy and Safety Study of ME1111 in Patients With Onychomycosis

Who this might be right for
Onychomycosis
Meiji Seika Pharma Co., Ltd. 304
Not applicableUnknownNCT03547414
What this trial is testing

Does Urinary TIMP2 and IGFBP7 Can Identify High Risk Patients of Progression From Mild and Moderate to Severe Acute Kidney Injury During Septic Shock?

Who this might be right for
Acute Kidney InjurySeptic Shock
Centre Hospitalier Universitaire, Amiens 110
Post-approval studies (Phase 4)Study completedNCT01504204
What this trial is testing

Effect of Samples on Acne Treatment With Epiduo® Gel

Who this might be right for
Acne Vulgaris
Wake Forest University 20
Testing effectiveness (Phase 2)Study completedNCT02113800
What this trial is testing

Safety and Tolerability of Everolimus as Second-line Treatment in Poorly Differentiated Neuroendocrine Carcinoma / Neuroendocrine Carcinoma G3 (WHO 2010) and Neuroendocrine Tumor G3 - an Investigator Initiated Phase II Study

Who this might be right for
Poorly Differentiated Malignant Neuroendocrine CarcinomaNeuroendocrine Carcinoma, Grade 3Neuroendocrine Carcinoma, Grade 1 [Well-differentiated Neuroendocrine Carcinoma] That Switched to G3+2 more
AIO-Studien-gGmbH
Testing effectiveness (Phase 2)Study completedNCT02210806
What this trial is testing

Albuterol DPI (A006) Clinical Study-B3:Efficacy, Dose-ranging and Safety Evaluation

Who this might be right for
Asthma
Amphastar Pharmaceuticals, Inc. 22
Large-scale testing (Phase 3)Study completedNCT00269438
What this trial is testing

New Tablet Formulation and Dosing Regimen of Balsalazide Disodium in Mildly to Moderately Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Bausch Health Americas, Inc. 225
Large-scale testing (Phase 3)Study completedNCT01872598
What this trial is testing

Masitinib in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
AB Science 721
Testing effectiveness (Phase 2)UnknownNCT04896606
What this trial is testing

SARS-CoV-2 CTLS for Mild to Moderate COVID-19 Disease

Who this might be right for
Covid19
New York Medical College 50
Testing effectiveness (Phase 2)Study completedNCT00151333
What this trial is testing

Study Evaluating SRA-333 in Mild to Moderate Alzheimer's Disease (AD)

Who this might be right for
Alzheimer's Disease
Wyeth is now a wholly owned subsidiary of Pfizer 16
Very early researchActive Not RecruitingNCT05111509
What this trial is testing

A First-in-human Clinical Trial to Evaluate an Alpha-radiation Imaging Agent

Who this might be right for
Neuroendocrine Tumor Grade 2Neuroendocrine Tumor Grade 1
Yusuf Menda 20
Large-scale testing (Phase 3)Study completedNCT00541684
What this trial is testing

Health Assessment Study (0954-946)

Who this might be right for
Hypertension
Organon and Co 143
Large-scale testing (Phase 3)Study completedNCT05506176
What this trial is testing

A Clinical Study to Evaluate the Efficacy and Safety of SIM0417 Orally Co-Administered With Ritonavir in Symptomatic Adult Participants With Mild to Moderate COVID-19

Who this might be right for
COVID-19
Jiangsu Simcere Pharmaceutical Co., Ltd. 1,208
Not applicableNot Yet RecruitingNCT06924840
What this trial is testing

A Clinical Study to Assess the Safety and Effectiveness of Utixira Lotion and Utixira Tablet in Healthy Adult Human Subjects With Dry or Sensitive Skin Prone to Mild to Moderate Pruritus and Urticaria

Who this might be right for
Dry SkinUrticariaPruritus+1 more
SAVA Healthcare Limited 32
Not applicableStudy completedNCT03384758
What this trial is testing

Evaluation of Compression Therapy in Patients With Mild to Moderate PAD or Diabetes Mellitus

Who this might be right for
Peripheral Arterial DiseaseDiabetes MellitusLeg Edema
University Hospital Erlangen 94
Large-scale testing (Phase 3)Ended earlyNCT04523090
What this trial is testing

Catalysing the Containment of COVID-19

Who this might be right for
COVID-19
University of Cape Town 322
Early research (Phase 1)Looking for participantsNCT06881290
What this trial is testing

Vunakizumab for the Treatment of Mild to Moderate Systemic Lupus Erythematosus

Who this might be right for
Lupus Erythematosus, Systemic
Chinese SLE Treatment And Research Group 20
Testing effectiveness (Phase 2)Study completedNCT00930059
What this trial is testing

PF-04447943 Compared To Placebo In Subjects With Mild To Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Pfizer 191
Load More Results
40